Biotech · Private company · Waltham, MA, US
Arsenal Medical, Inc.
Track this companyFree. Adds Arsenal Medical, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- NeoCast Embolic SystemSubdural HematomaClinicalTrials.gov · fetched Nov 12, 2026
- Onyx LES, an FDA-Approved Commercial Liquid EmbolicSubdural HematomaClinicalTrials.gov · fetched Nov 12, 2026
- ResQFoamHemorrhagic ShockClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- MMA Embolization With NeoCast for Subacute and Chronic Subdural HematomaNA · RECRUITING · started Aug 13, 2026ClinicalTrials.gov NCT07541404 · fetched Nov 12, 2026
- REVIVE: Reducing Exsanguination Via In-Vivo Expandable FoamNA · RECRUITING · started Aug 7, 2025ClinicalTrials.gov NCT02880163 · fetched Nov 12, 2026
NIH awards2
- RADIANT: A Pivotal Clinical Study of a Next-Generation Embolic for Chronic Subdural HematomaFiscal year 2026 · $2.2MNIH RePORTER 1SB1AG102149-01 · fetched Nov 12, 2026
- Engineering a Middle Meningeal Artery Embolization Model with Hydrophilicity and Hydraulic ResistanceFiscal year 2025 · $314.4KNIH RePORTER 1R43NS145940-01 · fetched Nov 12, 2026